Apyx™ Medical Corporation (formerly known as Bovie® Medical Corporation) is an advanced energy technology company with a passion for elevating people’s lives through innovative products in the cosmetic and surgical markets. Known for its innovative Helium Plasma Technology, Apyx is solely focused on bringing transformative solutions to the physicians and patients it serves. The company’s Helium Plasma Technology is marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion offers plastic surgeons, fascial plastic surgeons and cosmetic physicians a unique ability to provide controlled heat to the tissue to achieve their desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. The Company also leverages its deep expertise and decades of experience in unique waveforms through original equipment manufacturing (OEM) agreements with other medical device manufacturers.
Apyx Medical Corporation
5115 Ulmerton Road • Clearwater, FL 33760-4004 • USA
Ph +1 727 384 2323
BOARD OF DIRECTORS
Andrew Makrides, Esq., Executive Chairman of the Board of Directors | Bio
Charles D. Goodwin, Chief Executive Officer & Director | Bio
John Andres, Director | Bio
Michael Geraghty, Director | Bio
Craig A. Swandal, Director | Bio
Lawrence J. Waldman, CPA, Director | Bio
Minnie Baylor-Henry, Director, Chair of Regulatory and Compliance Committee | Bio
NEWS & PRESS RELEASE ARCHIVE
COMPANY INVESTOR PRESENTATION
FIRST QUARTER OF FISCAL YEAR 2021 FINANCIAL RESULTS
Management hosted a conference call at 8:00 a.m. Eastern Time on May 12 to discuss the results of the quarter, and to host a question and answer session. To listen, click the REPLAY button below.
Apyx Medical will participate in the JMP Securities Life Sciences Conference June 16th-17th. Management will participate in a fireside chat on Wednesday, June 16th at 10:30 a.m. Eastern Time.
TRANSFER AGENT CONTACT:
Manhattan Transfer Registrar Co.
Ph +1 631 928 7655
- CORPORATE GOVERNANCE GUIDELINES
- AUDIT COMMITTEE CHARTER
- COMPENSATION COMMITTEE CHARTER
- GOVERNANCE AND NOMINATION COMMITTEE CHARTER
- REGULATORY COMPLIANCE COMMITTEE CHARTER
- CODE OF ETHICS AND CONDUCT
- SUNSHINE ACT / OPEN PAYMENT PROGRAM
- NOTICE OF PROPOSED SETTLEMENT AND SETTLEMENT HEARING
- CONFLICT MINERALS DISCLOSURE REPORT